Back
Day Range
$59.98
$61.87
52-Week Range
$45.00
$85.84
Volume
579,981
50D / 200D Avg
$69.11
/
$69.40
Prev Close
$59.87
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -252.4 | 0.2 |
| P/B | 4.3 | 3.0 |
| ROE % | -1.9 | 3.6 |
| Net Margin % | -0.9 | 3.8 |
| Rev Growth 5Y % | 11.6 | 9.7 |
| D/E | 1.7 | 0.2 |
Analyst Price Target
Hold
$92.00
+51.7%
Low: $90.00
High: $95.00
Forward P/E
96.03
Forward EPS
$0.63
EPS Growth (est.)
+0.0%
Est. Revenue
2.46B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$1.18
$1.13 – $1.23
|
3.03B | 2 |
| FY2027 |
$1.01
$0.80 – $1.22
|
2.72B | 3 |
| FY2026 |
$0.63
$0.39 – $0.85
|
2.46B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-02 | $0.20 | $0.23 | +12.6% |
| 2025-11-09 | $0.22 | $0.20 | -10.3% |
| 2025-08-10 | $0.17 | $0.31 | +82.4% |
| 2025-05-11 | -$0.17 | -$0.35 | -105.9% |
| 2025-02-27 | $0.21 | $0.22 | +4.8% |
| 2024-11-10 | $0.14 | $0.18 | +32.5% |
| 2024-08-07 | $0.16 | $0.16 | 0.0% |
| 2024-05-08 | -$0.09 | $0.07 | +177.8% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 11.60% annually over 5 years — strong growth
Earnings declined -767.81% over the past year
Generating 85.57M in free cash flow
PEG of 0.38 suggests growth is underpriced
ROIC of 2.31% — low return on invested capital
Interest coverage of 1.30× — tight debt servicing
Growth
Revenue Growth (5Y)
11.60%
Revenue (1Y)11.51%
Earnings (1Y)-767.81%
FCF Growth (3Y)39.04%
Quality
Return on Equity
-1.87%
ROIC2.31%
Net Margin-0.91%
Op. Margin4.45%
Safety
Debt / Equity
1.71
Current Ratio1.76
Interest Coverage1.30
Valuation
P/E Ratio
-252.41
Forward P/E96.03
P/B Ratio4.32
EV/EBITDA63.87
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.51% | Revenue Growth (3Y) | 12.34% |
| Earnings Growth (1Y) | -767.81% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11.60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.04B | Net Income (TTM) | -18.65M |
| ROE | -1.87% | ROA | -0.50% |
| Gross Margin | 4.45% | Operating Margin | 4.45% |
| Net Margin | -0.91% | Free Cash Flow (TTM) | 85.57M |
| ROIC | 2.31% | FCF Growth (3Y) | 39.04% |
| Safety | |||
| Debt / Equity | 1.71 | Current Ratio | 1.76 |
| Interest Coverage | 1.30 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -252.41 | Forward P/E | 96.03 |
| P/B Ratio | 4.32 | P/S Ratio | 2.31 |
| PEG Ratio | 0.38 | Forward PEG | N/A |
| EV/EBITDA | 63.87 | Fwd EV/EBITDA | 13.89 |
| Forward P/S | 1.92 | Fwd Earnings Yield | 1.04% |
| FCF Yield | 1.82% | ||
| Market Cap | 4.71B | Enterprise Value | 5.80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.04B | 1.83B | 1.62B | 1.43B | 1.32B |
| Net Income | -18.65M | 2.79M | 3.04M | 10.65M | 24.73M |
| EPS (Diluted) | -0.25 | 0.04 | 0.05 | 0.17 | 0.46 |
| Gross Profit | 90.80M | 249.12M | 221.39M | 165.72M | 191.80M |
| Operating Income | 90.80M | 104.62M | 98.70M | 46.36M | 82.55M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.76B | 3.29B | 2.69B | 2.43B | 2.06B |
| Total Liabilities | 2.40B | 2.15B | 1.88B | 1.94B | 1.71B |
| Shareholders' Equity | 1.09B | 902.31M | 630.70M | 333.00M | 228.90M |
| Total Debt | 1.86B | 1.73B | 1.49B | 1.51B | 1.40B |
| Cash & Equivalents | 767.22M | 740.02M | 342.57M | 127.83M | 134.61M |
| Current Assets | 1.03B | 1.02B | 579.28M | 367.18M | 324.26M |
| Current Liabilities | 586.76M | 479.71M | 437.45M | 466.72M | 374.78M |